Description

4-(2,5-Dimethyl-5,6,7,8-Tetrahydro-Benzo[4,5]-Thieno[2,3-D]Pyrimidin-4-Ylamino)-Butyric Acid CAS NO 886499-65-6 is a high-purity, advanced pharmaceutical intermediate featuring a complex heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing targeted small-molecule drugs.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• Kinase Inhibitor Development: Serves as a core scaffold or precursor for compounds designed to modulate kinase activity.
• Chemical Biology Probes: Utilized in the development of molecular probes to study biological processes and protein function.
• Custom Synthesis: Starting material for the contract manufacturing of specialized, high-value fine chemicals.
• Academic Research: Employed in university and institutional labs for exploratory synthetic chemistry and pharmacology projects.

Basic Information

Product Name	4-(2,5-Dimethyl-5,6,7,8-Tetrahydro-Benzo[4,5]-Thieno[2,3-D]Pyrimidin-4-Ylamino)-Butyric Acid
CAS No.	886499-65-6
Molecular Formula	C₁₈H₂₃N₃O₂S
Molecular Weight	345.46 g/mol
Synonyms	4-[(2,5-Dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]butanoic acid; 4-((2,5-Dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino)butyric acid; Butanoic acid, 4-[(2,5-dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]-; 886499-65-6; BDBM50164657; ZINC000003869677; AKOS005147209; FT-0775787
EINECS	Contact for details

Quality Control

Our production of 4-(2,5-Dimethyl-5,6,7,8-Tetrahydro-Benzo[4,5]-Thieno[2,3-D]Pyrimidin-4-Ylamino)-Butyric Acid adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis. We provide a detailed Certificate of Analysis (COA) with each shipment, ensuring traceability and compliance with cGMP standards for pharmaceutical intermediates. Our quality system is designed to meet the exacting requirements of global R&D and pre-clinical manufacturing.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The product is moisture-sensitive; ensure the container is kept sealed in a dry environment to prevent degradation. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Retention time corresponds to reference standard
Identification (NMR)	Spectrum consistent with structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.